drugset / Trial / NCT03206463

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder

NCT03206463

Phase 1 Terminated 2 enrolled Yale University
RandomizedCrossoverQuadruple-blindBasic science

Summary

The overarching goal of this study is to characterize the acute cognitive and psychophysiological effects of the main psychoactive constituent of cannabis, 9-delta-tetrahydrocannabinol (THC) in individuals with euthymic bipolar disorder (BD), and to begin probing the mechanisms that may underlie its effects in this illness. This study is expected to contribute to a better characterization of specific effects of THC in individuals with BD compared to healthy controls (HC).

Timeline

Start
2017-08-01
Primary completion
2017-09-29
Completion
2017-09-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 2 mg Inhaled
Subject Dronabinol Other / unclassified 4 mg Inhaled

Indications